Speakers

PLENARY KEYNOTE:

Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical Institute; Professor of Genetics, Harvard Medical School; Nobel Laureate

Anti-inflammatories: Small Molecule Approaches

 

Jean-Luc Galzi, Ph.D., Professor, Biotechnology and Cellular Signaling, University of Strasbourg

Jean-Luc Girardet, Ph.D., Vice President, Chemistry & Development Support, Ardea Biosciences, Inc.

Jan Hoflack, Ph.D., Head, Drug Discovery, ONCODESIGN Biotechnology

Hayat Onyuksel, Ph.D., Professor, Biopharmaceutical Sciences, University of Illinois at Chicago

Samarjit Patnaik, Ph.D., Research Scientist, National Center for Advancing Translational Sciences, NIH

Peter H. Schafer, Ph.D., Senior Principal Investigator, Translational Development, Celgene Corporation

C. Eric Schwartz, Ph.D., Senior Director, Chemistry, Celgene Avilomics Research

Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical Institute; Professor of Genetics, Harvard Medical School; Nobel Laureate

Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.

Suvit Thaisrivongs, Ph.D., Executive Director, Chemistry, Pfizer

Jennifer Venable, Ph.D., Senior Scientist, Immunology Chemistry, Johnson & Johnson Pharmaceutical R&D

Longcheng Wang, Ph.D., Research Scientist III, Medicinal Chemistry, Pharmacyclics

Daigen Xu, M.D., Ph.D., Research Leader, Inflammation Discovery, Hoffman La-Roche

Mark Zak, Ph.D., Scientist, Discovery Chemistry, Genentech

Fragment-Based Drug Discovery

 

Rommie E. Amaro, Ph.D., Assistant Professor, Department of Chemistry, University of California, San Diego

Carol Austin, Ph.D., Biology Group Leader, Selcia Ltd

Justin Bower, Ph.D., Head, Chemistry, Drug Discovery Programme, The Beatson Institute for Cancer Research

Fabrizio Giordanetto, Ph.D., Project Leader - Principal Scientist, Medicinal Chemistry, CVGI iMed, AstraZeneca R&D

Roderick E. Hubbard, Ph.D., Senior Scientist, Vernalis Ltd.

Peter S. Kutchukian, Ph.D., Presidential Postdoctoral Fellow, Novartis Institutes for BioMedical Research, Cambridge, MA

Alex MacKerell, Ph.D., Grollman-Glick Professor of Pharmaceutical Sciences; Director, Computer-Aided Drug Design Center School of Pharmacy University of Maryland

Julen Oyarzabal, Ph.D., Director, Small Molecule Discovery Platform, Center for Applied Medical Research (CIMA), University of Navarra

Joerg Scheuermann, Ph.D., Senior Scientist, MoB, Pharmaceutical Sciences, ETH Zurich

David Soriano del Amo, Ph.D., Head, Med. Chemistry, Acelelra Ltd.

Joe Sweeney, Ph.D., Professor of Catalysis and Chemical Biology, Department of Chemistry, University of Huddsfield

Richard Taylor, Ph.D., Principal Scientist, CADD, UCB

Heather Twin, Ph.D., Research Scientist, Vertex Pharmaceuticals

Chris Williams, Ph.D., Principal Scientist, Chemical Computing Group

Edward T. Zartler, Ph.D., President and CSO, Quantum Tessera Consulting and ZoBio

Constrained Peptides and Macrocyclics Drug Discovery

 

Steven Ballet, Ph.D., Research Group of Organic Chemistry, Departments of Bio-Engineering Sciences and Chemistry, Vrije Universiteit Brussel

Christophe Bonny, Ph.D., CSO, Bicycle Therapeutics Limited

Julio Camarero, Ph.D., Associate Professor, Pharmacology and Chemistry, University of Southern California

Jennifer Cochran, Ph.D., Associate Professor, Bioengineering, Stanford University

Sarah Dong, Ph.D., Senior Scientist II, Chemistry Department, Affymax, Inc.

Ian Lewis, Ph.D., Research Chemist, Global Discovery Chemistry, Novartis

Daniel Obrecht, Ph.D., CSO, Polyphor, Ltd.

Dinesh Patel, Ph.D., CEO, Protagonist Therapeutics

Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics

Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical Institute; Professor of Genetics, Harvard Medical School; Nobel Laureate

Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.

Helmut Thomas, Ph.D., Senior Vice President, Research and Pre-Clinical Development, Tranzyme Pharma

Douglas A. Treco, Ph.D., President and CEO, Ra Pharmaceuticals

Christoph Zapf, Ph.D., Principal Scientist, Worldwide Medicinal Chemistry, Pfizer

Kinase Inhibitor Chemistry

Toru Asano, Ph.D., Scientist, Drug Discovery Research, Astellas Pharma, Inc.

Ann Aulabaugh, Ph.D., Senior Scientist, Structural Biology and Biophysics, Pfizer

David Chantry, Ph.D., Senior Director, Translational and Cellular Biology, Array BioPharma

Olivier Defert, Ph.D., Amakem NV

Anthony Estrada, Ph.D., Scientist, Medicinal Chemistry, Genentech, Inc.

Kristine E. Frank, Ph.D., Senior Scientist III, Hit to Lead Chemistry, Abbvie

Leyi Gong, Ph.D., Scientist, SRI International

Seungil Han, Ph.D., Senior Principal Scientist, Pfizer

Jan Hoflack, Ph.D., Head, Drug Discovery, ONCODESIGN Biotechnology

Sarah G. Hymowitz, Ph.D., Director, Department of Structural Biology, Genentech, Inc.

Ramesh Jha, Ph.D., Scientist, Bioscience Division, B10, MS M888, Los Alamos National Laboratory

Deborah J. Moshinsky, Ph.D., Founder and President, Cell Assay Innovations, LLC.

Tom Smithgall, Ph.D., William S. McEllroy Professor of Biochemistry, Chair, Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine

Hongtao Zhao, Ph.D., Scientist, Biochemistry, University of Zurich

Protein-Protein Interactions

Cheryl Arrowsmith, Ph.D., Professor, Medical Biophysics; Canada Research Chair in Structural Proteomics, University of Toronto

Carol Austin, Ph.D., Biology Group Leader, Selcia Ltd
Asfar Azmi, Ph.D., Research Scientist, Pathology and Oncology, Karmanos Cancer Institute, Wayne State University

James Bibb, M.D., Associate Professor, Psychiatry and Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center

Peter Buchwald, Ph.D., Director, Drug Discovery, Diabetes Research Institute, University of Miami

David Fry, Ph.D., Head, Biostructural Research, Hoffman-La Roche

Chang-Deng Hu, M.D., Ph.D., Associate Professor, Medicinal Chemistry and Molecular Pharmacology, Purdue University

Michael Hodsdon, M.D., Ph.D., Associate Professor, Laboratory Medicine, Yale University

David Koes, Ph.D., Research Assistant Professor, Computational and Systems Biology, University of Pittsburgh

Jarek Meller, Ph.D., Associate Professor, Environmental Health, University of Cincinnati

Xavier Morelli, Ph.D., Group Leader & Principal Investigator, CRCM, CNRS

Nir Qvit, Ph.D., Research Associate, Chemical and Systems Biology, Stanford University

Tomi K. Sawyer, Ph.D., CSO, Aileron Therapeutics

Adam G. Schrum, Ph.D., Assistant Professor of Immunology, Mayo Clinic College of Medicine

Woody Sherman, Vice President, Applications Science, Schrödinger

Olivier Sperandio, Ph.D., Drug Designer - CDithem Platform, Senior Research Associate, Inserm

GPCR-Based Drug Design: Computational and Structural Approaches 

 

Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego

Vadim Cherezov, Ph.D., Assistant Professor, Department of Molecular Biology, The Scripps Research Institute

Robert Cooke, Ph.D., Head, Biomolecular Structure Department, Heptares

Karen J. Gregory, Ph.D., Post-Doctoral Fellow, Jeffrey Conn Laboratory, Pharmacology, Vanderbilt University

Reinhard Grisshammer, Ph.D., Investigator, National Institute of Neurological Disorders and Stroke (NINDS), NIH

Andrew C. Kruse, Graduate Student, Brian Kobilka (2012 Nobel Laureate) Lab, Department of Molecular and Cellular Physiology, Stanford University

Christopher A. Reynolds, Ph.D., MRC Fellow, Professor, School of Biological Sciences, University of Essex

Hugh Rosen, M.D., Ph.D., Professor, Chemical Physiology, Scripps Research Institute

Carleton Sage, Ph.D., Fellow, Computational Systems, Arena

Thomas P. Sakmar, M.D., Professor, Laboratory of Chemical Biology & Signal Transduction, The Rockefeller University

Jan Steyaert, Ph.D., Executive Director and Professor, Molecular and Cellular Interactions, Free University Brussels

Nagarajan Vaidehi, Ph.D., Professor, Immunology, Beckman Research Institute of the City of Hope

Graham West, Ph.D., Postdoctoral Associate, Molecular Therapeutics, The Scripps Research Institute, Scripps Florida